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Abstract We investigated the localization of non-muscle
myosin II isoforms and mono- (at serine 19) and diphos-
phorylated (at serine 19 and threonine 18) regulatory light
chains (RLCs) in motile and non-motile MRC-5 fibroblasts. In
migrating cells, myosin IIA localized to the lamella and
throughout the posterior region. Myosin IIB colocalized with
myosin IIA to the posterior region except at the very end.
Diphosphorylated RLCs were detected in the restricted region
where myosin IIA was enriched. In non-motile cells, myosin IIA
was enriched in peripheral stress fibers with diphosphorylated
RLCs, but myosin IIB was not. Our results suggest that myosin
IIA may be highly activated by diphosphorylation of RLCs and
primarily involved in cell migration. ß 2001 Published by
Elsevier Science B.V. on behalf of the Federation of European
Biochemical Societies.
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1. Introduction
Myosin II, one of the best-studied members of the myosin
superfamily, plays an important role in cell migration [1,2].
Myosin II-based contraction has been implicated in the gen-
eration of forces to maintain a polarized cell shape, and the
direction of migration. In migrating Dictyostelium, myosin II
is concentrated in the posterior region where it plays a role in
uropodal retraction [3]. On the other hand, in migrating ver-
tebrate cultured cells it has been demonstrated that myosin II
is present in the lamella, as well as in the posterior region,
using various methods such as immuno£uorescence in ¢xed
cells [4], microinjection of £uorescent analogs [5^7] and elec-
tron microscopy [8,9]. The contractility of an actin^myosin II
complex both in the lamella and the posterior region is in-
volved in cell migration.
In vertebrate cells, there are at least two di¡erent isoforms
of the non-muscle myosin heavy chain (MHC) referred to as
MHC-IIA and MHC-IIB, which together with two pairs of
light chains forms myosin IIA and myosin IIB, respectively
[10^13]. To date, subcellular localization of these isoforms has
been investigated in order to understand their unique func-
tions at a cellular level [14^20]. These observations suggested
that there are di¡erences in localization between myosin IIA
and IIB. However, no consensus as to these di¡erences has
emerged, including their localization in migrating cells.
The activities of non-muscle myosin II are regulated by
phosphorylation of the regulatory light chains (RLCs) at ser-
ine 19 in a manner similar to smooth muscle myosin II [21,22].
Phosphorylation at this site increases the actin-activated
Mg2-ATPase activity and the rate of movement of actin
¢lament. Under some conditions, threonine 18 of the RLCs
is also phosphorylated in addition to serine 19 [23]. This di-
phosphorylation results in increasing the actin-activated
Mg2-ATPase activity compared with monophosphorylated
myosin at serine 19 [24^26]. It has also been demonstrated
that the cytoskeletal fraction of cultured endothelial cells con-
tains monophosphorylated and diphosphorylated myosin II
[27]. The localization of monophosphorylated myosin II was
demonstrated in motile and non-motile cells [28^31], but that
of diphosphorylated myosin II was only demonstrated in cul-
tured smooth muscle cells [32].
In this study, we investigated the immunolocalization of
non-muscle myosin II isoforms and their phosphorylated
RLCs, in motile and non-motile ¢broblasts. Our results indi-
cate that myosin IIA may largely function in order to generate
force in migrating cells as well as in stationary cells.
2. Materials and methods
2.1. Antibodies
Anti-human MHC-IIB polyclonal antibody (pAb) was produced
against a synthetic peptide, S-D-V-N-E-T-Q-P-P-Q-S-E (carboxyl-ter-
minus of human non-muscle MHC-IIB). Immunization and puri¢ca-
tion of the antibody were performed according to a published proto-
col [33]. Anti-MHC-IIA pAb was a kind gift of Dr. Robert S.
Adelstein (NHLBI, NIH). Anti-MHC-IIB monoclonal antibody
(mAb) was a kind gift of Dr. Tomoaki Shirao (Gunma University).
Anti-vinculin mAb was purchased from Sigma-Aldrich. £uorescein
isothiocyanate (FITC)-conjugated anti-rabbit IgG antibody and
Cy3-conjugated anti-mouse IgG antibody were purchased from Jack-
son ImmunoResearch Lab. The antibody P1 was characterized as
described previously [30]. The antibody PP1 was produced against a
diphosphorylated peptide, K-R-P-Q-R-A-phospho T-phospho S-N-V-
F, and the detailed characterization was described in another paper
[34].
2.2. Preparation of total cell extracts and immunoprecipitation
MRC-5 cells were obtained from the Riken Cell Bank (Tsukuba,
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Japan) and were grown in MEM1 medium (Nissui) with 10% fetal
bovine serum (ICN Biomedicals). Total cell extracts were prepared as
follows: cells were homogenized in an extraction bu¡er (20 mM Tris^
HCl (pH 7.5), 150 mM NaCl, 1% IGEPAL CA-630 (Sigma-Aldrich),
5 mM EDTA, 5 mM EGTA, 1 mM DTT, 50 mM NaF, 5 mM ATP,
0.1 mM PMSF and 5 Wg/ml leupeptin) via several passages through a
26-gauge needle. A portion of the homogenate was used as a total cell
extract for sodium dodecyl sulfate (SDS)^polyacrylamide gel electro-
phoresis (PAGE). Immunoprecipitation was performed as follows. In
brief, the homogenates were centrifuged at 15 000Ug and the resulting
supernatants were immunoprecipitated with anti-MHC-IIA or anti-
MHC-IIB pAbs crosslinked to Protein A-Sepharose beads (Amer-
sham Pharmacia Biotech) by rotating overnight at 4‡C. The immuno-
complexes were washed four times in a wash bu¡er (20 mM Tris^HCl
at pH 7.5, 0.5 M NaCl, 1% IGEPAL CA-630, 5 mM EDTA, 5 mM
EGTA and 1 mg/ml BSA) and then rinsed with phosphate-bu¡ered
saline (PBS) three times. For SDS^PAGE, the immunoprecipitates
were eluted in 2USDS sample bu¡er with boiling for 3 min.
2.3. SDS^PAGE and immunoblotting
Total cell extracts and immunoprecipitates were separated on SDS^
5% polyacrylamide gels with 0.065% bisacrylamide, using the bu¡er
system of Laemmli [35]. The gel was electro-transferred onto Immo-
bilon transfer membranes (Millipore). The membranes were incubated
with 1% non-fat skim milk in PBS at room temperature for 30 min
followed by immunostaining with speci¢c anti-sera against MHC-IIA
(1:1000) or IIB (1:500) overnight at 4‡C. Immunoreactivity was de-
tected with horseradish peroxidase-conjugated secondary antibody
(1:500) (ICN Biomedicals) and 4-chloro-1-naphthol as a substrate.
2.4. Indirect immuno£uorescence
MRC-5 cells grown on coverslips were ¢xed in 3.7% formaldehyde
in PBS for 10 min, permeabilized in PBS containing 0.1% Triton X-
100 for 10 min and rinsed with PBS three times. The ¢xed cells were
incubated with primary antibodies for 1 h at the following concen-
trations: anti-MHC-IIA pAb (1:1500), anti-MHC-IIB pAb (1:1500),
anti-MHC-IIB mAb (1:2), P1 (1:20), PP1 (1:10) and anti-vinculin
mAb (1:500). Indirect immunolabeling was performed by incubation
with FITC-conjugated anti-rabbit IgG antibody (1:200) and Cy3-con-
jugated anti-mouse IgG antibody (1:500) as secondary antibodies for
1 h. The cells were examined using a conventional £uorescence micro-
scope (BX50WI, Olympus), equipped with a color chilled 3CCD cam-
era (M3204-C, Olympus). A confocal laser scanning microscope
(PCM2000, Nikon) was used to visualize the localization of vinculin.
3. Results
3.1. Subcellular localization of non-muscle myosin IIA and IIB
in motile and non-motile ¢broblasts
In order to understand the function of non-muscle myosin
II isoforms during cell migration, we investigated the local-
ization of myosin IIA and IIB in motile and non-motile ¢bro-
blasts. Immunoblot analyses of total cell extracts demon-
strated that both isoforms of non-muscle myosin II were
expressed in human MRC-5 ¢broblast cells (Fig. 1). Fig. 1
also shows that MHC-IIA and MHC-IIB were immunopre-
cipitated separately with isoform-speci¢c antibodies, indicat-
ing that MHC-IIA and MHC-IIB do not form heterodimers
in MRC-5 cells.
The localization of these isoforms was visualized by indirect
immuno£uorescence using anti-MHC-IIA pAb and anti-
MHC-IIB mAb. In migrating cells, the £uorescent signal of
myosin IIA was strongly detected close to the leading edge, as
well as throughout the posterior region (Fig. 2A). It was
noted that the signal was detected along transverse ¢ber struc-
tures in the lamella. Myosin IIB colocalized with myosin IIA
in the posterior region except at the very end, but it was low
or absent in the anterior region (Fig. 2B,C). That is, the iso-
form preferentially located in the anterior region of migrating
¢broblasts was myosin IIA (Fig. 2C). In non-motile cells, both
isoforms were detected in stress ¢bers (Fig. 2D,E). Myosin
IIA was found throughout stress ¢bers, but myosin IIB was
low or absent in the peripheral ¢bers (Fig. 2F).
3.2. Distribution of mono- and diphosphorylated myosin RLCs
in motile and non-motile ¢broblasts
The antibodies referred to as P1 and PP1 speci¢cally react
Fig. 1. Expression of non-muscle myosin II isoforms in human
MRC-5 ¢broblast cells. Lanes 1 and 4 are total cell extracts. Lanes
2 and 5 are immunoprecipitates using anti-MHC-IIA pAb. Lanes 3
and 6 are immunoprecipitates using anti-MHC-IIB pAb. Immuno-
blot was performed with anti-MHC-IIA (lanes 1^3) or anti-MHC-
IIB (lanes 4^6) anti-sera.
Fig. 2. Subcellular localization of non-muscle myosin II isoforms in MRC-5 cells. Myosin IIA (A,D) was detected using anti-MHC-IIA pAb
and an FITC-conjugated secondary antibody. Myosin IIB (B,E) was detected using anti-MHC-IIB mAb and a Cy3-conjugated secondary anti-
body. A^C: Motile cells. D^F: Non-motile cells. C,F: Merged images. The green and red colors indicate myosin IIA and IIB, respectively. Yel-
low indicates area of colocalization. Bars: A^C: 20 Wm; D^F: 10 Wm.
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with monophosphorylated (at serine 19) and diphosphory-
lated (at serine 19 and threonine 18) RLCs, respectively. In
migrating cells, P1 stained throughout the posterior region
strongly, and the anterior region close to the leading edge
stained slightly (Fig. 3A). PP1 stained in limited regions com-
pared to P1, i.e. some ¢ber structures including transverse
¢ber-like structures close to the leading edge and also a por-
tion of the cell cortex in the posterior region (Fig. 3B).
Merged images of PP1 and anti-MHC-IIB mAbs revealed
that the myosin II isoform which was highly activated in
the anterior region was not myosin IIB (Fig. 3D). In non-
motile cells, P1 stained throughout stress ¢bers (Fig. 3E).
PP1 stained the peripheral stress ¢bers in which myosin IIA
was enriched but myosin IIB was absent (Fig. 3F^H). These
results suggest that only myosin IIA is especially activated
because the distribution of diphosphorylated RLCs was sim-
ilar to that of the myosin IIA heavy chains. Although colo-
calization of myosin IIB and diphosphorylated RLCs was
observed in shortened stress ¢bers (Fig. 3H), myosin IIA
was also present (Fig. 4A). Unfortunately, we could not per-
form double-staining of MHC-IIA and diphosphorylated
RLCs, because the anti-MHC-IIA pAb and PP1 were both
rabbit polyclonal antibodies. P1 and PP1 also stained nuclei,
but the signi¢cance of this is unclear.
3.3. Localization of diphosphorylated RLCs and focal adhesion
(FA) protein
In order to understand the relation between the distribution
of highly activated myosin II molecules in stress ¢bers and
FAs, we observed non-motile cells double-stained with PP1
and anti-vinculin mAb by confocal microscopy. Myosin IIA
was present in stress ¢bers whose ends linked to FAs (Fig.
4A). However, the tips of stress ¢bers immunostained with
myosin IIB mAb did not link to FAs (Fig. 4B). PP1 stained
the peripheral stress ¢bers whose ends linked to FAs as well as
myosin IIA (Fig. 4C). It was noted that diphosphorylated
RLCs were detected throughout shortened stress ¢bers whose
ends linked to FAs (Fig. 4D).
4. Discussion
In polarized migrating cells, myosin IIA was distributed
within lamellae and throughout the posterior regions of cells.
On the other hand, myosin IIB was low or absent in the
anterior region but was detected in a part of the posterior
region. These results are similar to the observation in living
endothelial cells [18], but the di¡erence between myosin IIA
and IIB was much more obvious in the ¢broblast cells in this
study. In addition, we show here that the diphosphorylated
RLCs dramatically localized in some ¢bers including trans-
verse ¢bers in lamella where myosin IIA was present. This
suggests that myosin IIA within lamella is highly activated
by phosphorylation at both serine 19 and threonine 18 of its
RLCs. It is thought that contraction of an actin^myosin II
network in lamella is coupled to forward translocation of the
cell body [2]. In particular, the contraction of transverse ¢bers
within lamellae could be necessary to maintain a polarized cell
shape and the direction of migration [6]. In the posterior
region of migrating cells, monophosphorylated RLCs were
di¡usely distributed in the cytoplasm, which was similar to
earlier studies [28,29], whereas diphosphorylated RLCs were
concentrated in a part of the cell cortex. At present, it is
unclear which isoform of myosin II was diphosphorylated,
because both isoforms colocalized there. Myosin II-mediated
contraction is believed to generate force to retract the cells in
the posterior region [1,2], and maintain a polarized cell shape
and direction of migration by inhibiting extension of lamelli-
podia in the lateral and posterior region [6,36]. Our results
indicate that highly activated myosin II could be related to the
latter function. Our observations in polarized migrating cells
suggest that myosin IIA would primarily be responsible for
cell migration in general and myosin IIB would support the
function of myosin IIA in the posterior region.
In non-motile ¢broblasts, we observed that both isoforms
of myosin II were located in stress ¢bers but that the periph-
ery was enriched in myosin IIA. This distribution of non-
muscle myosin II isoforms in non-motile cells is similar to
Fig. 3. Distribution of phosphorylated RLCs and myosin IIB in MRC-5 cells. Monophosphorylated RLCs (A,E) were detected with P1 and an
FITC-conjugated secondary antibody. Diphosphorylated RLCs (B,F) were detected using PP1 and an FITC-conjugated secondary antibody.
Myosin IIB (C,G) was detected using anti-MHC-IIB mAb and a Cy3-conjugated secondary antibody. A^D: Motile cells. E^H: Non-motile
cells. D: Merged image of B and C. H: Merged image of F and G. The green and red colors indicate diphosphorylated RLCs and myosin
IIB, respectively. Yellow indicates area of colocalization. Arrows indicate shortened stress ¢bers (F^H). Bars: A^D, F^H: 20 Wm; E: 10 Wm.
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observations in interphase melanoma cells [15]. The periph-
eries of stress ¢bers are linked to FAs. Smilenov et al. dem-
onstrated that FAs are highly motile toward the cell center in
non-motile cells and that the contractility of myosin II is
necessary for this FA movement [37]. They suggest that cells
are able to polarize rapidly toward migratory cues by main-
taining FAs in a motile ‘idling’ state. It has been demon-
strated that myosin IIA is required for the function of FAs
in neuroblastoma cells [38] and in glial cells [39]. We showed
that diphosphorylated RLCs were enriched in the peripheral
stress ¢bers, where myosin IIB was absent but myosin IIA
was present. Thus, myosin IIA might be preferentially diphos-
phorylated and highly activated in non-motile cells also, since
it may be required for the idling state of FAs. We also showed
that diphosphorylated RLCs were found throughout short-
ened stress ¢bers. Our data suggests that myosin IIA would
be predominantly diphosphorylated, although both isoforms
are present in the shortened stress ¢bers.
Which kinase(s) phosphorylate non-muscle myosin II at
both serine 19 and threonine 18? It is known that myosin
light chain kinase (MLCK) phosphorylates at both serine 19
and threonine 18 of RLCs. However, phosphorylation of
threonine 18 by MLCK is much slower than that of serine
19 [23]. This indicates that threonine phosphorylation may
not be due to MLCK. Recently, zipper-interacting protein
kinase (ZIPK) was found to phosphorylate the RLC of
non-muscle and smooth muscle myosin II at both serine 19
and threonine 18 [40,41]. Phosphorylation of the RLC at both
serine 19 and threonine 18 occurs at the same rate in smooth
muscle cells [41]. Consequently, it is possible that ZIPK could
phosphorylate the RLC of non-muscle myosin II at both ser-
ine 19 and threonine 18 in motile and non-motile ¢broblasts.
In conclusion, we have demonstrated that non-muscle my-
osin IIA and IIB revealed a distinct pattern of localization
and, moreover, myosin IIA may be preferentially phosphory-
lated at both serine 19 and threonine 18. Interestingly, diphos-
phorylated RLCs showed more restricted distribution than
monophosphorylated RLCs. These results raise the possibility
that non-muscle myosin II isoforms may participate in cell
migration in an isoform-dependent manner.
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